JACLYN AGOPIAN: Open Payments
NPI 1053629121 · SHERMAN OAKS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$16,805 in 105 payments from 20 companies in 2025. Trend: 2023 $24,998 · 2024 $11,525 · 2025 $16,805
Speaker / faculty: $7,200Consulting: $5,250Food & beverage: $3,149Travel & lodging: $1,186Education: $19
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 22 | $6,128 |
| Kowa Pharmaceuticals America, Inc. | 7 | $5,324 |
| Galderma Laboratories, L.P. | 9 | $3,489 |
| UCB, Inc. | 6 | $348 |
| ABBVIE INC. | 10 | $225 |
| Incyte Corporation | 10 | $182 |
| Novartis Pharmaceuticals Corporation | 9 | $174 |
| E.R. Squibb & Sons, L.L.C. | 2 | $150 |
| Regeneron Healthcare Solutions, Inc. | 5 | $143 |
| GENZYME CORPORATION | 3 | $141 |
Products named: Zoryve, AKLIEF, Bimzelx, DUPIXENT, OPZELURA, Sotyktu, COSENTYX, NEMLUVIO.
Industry payments across CA — which companies pay providers there.
